… anti-phospholipid syndrome (APS) is characterized by the production of antibodies that
bind the phospholipid-… Emerging concepts in the molecular pathogenesis of systemic lupus …

… review is to examine the evolving understanding of APS pathogenesis and how this and
other therapeutic options will change the way we manage this potentially devastating disorder. …

… Anticardiolipin or Hughes syndrome, is a systemic autoimmune disorder characterized …
antiphospholipid antibodies (aPL). The contribution of the extra-criteria aPL to the pathogenesis …

… Moreover, aPL interacting with endothelial cells may induce the expression of adhesion
molecules such as intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, E-…

… antiphospholipid syndrome (… antiphospholipid antibodies such as lupus anticoagulant,
anti-β-2-glycoprotein 1, and/or anticardiolipin antibodies. In the obstetrical APS, antiphospholipid …

… of antiphospholipid syndrome (APS) are related to the activity of circulating antiphospholipid
… In this review, we describe the pathogenic mechanisms of APS through the key role of lipid …

Atherothrombosis is a frequent complication of the clinical history of patients with antiphospholipid
syndrome (APS). Both atherothrombosis and APS are characterized by increased …

… also key drivers of APS pathophysiology. Thrombotic events in … This review will highlight
known pathogenic factors in APS … a barrier that selectively permits molecular and cellular transit …

… the reduction of antioxidant molecules. This imbalance causes … -inflammatory and procoagulant
molecules, the formation of … stress in the pathogenesis of atherothrombosis associated …

… syndrome. The aim of this review is to investigate the state-of-the-art antiphospholipid syndrome
pathogenesis … examining all of the known pathogenetic mechanisms contributing to the …